Similar articles for PMID: 29061812

Year	Number of Results
1943	1
1956	1
1980	1
1999	1
2001	1
2002	3
2003	10
2005	3
2006	6
2007	15
2008	20
2009	13
2010	19
2011	21
2012	28
2013	17
2014	23
2015	19
2016	36
2017	38
2018	25
2019	18
2020	24
2021	20
2022	10
2024	0

1

Tumor Suppression Efficacy of Heat Shock Protein 90 Inhibitor 17AAG in a Liposarcoma Mouse Model.

Nam S, Kim H, Hong D, Park JB, Kim SJ. Nam S, et al. Anticancer Res. 2017 Nov;37(11):6291-6302. doi: 10.21873/anticanres.12080. Anticancer Res. 2017. PMID: 29061812

2

Targeting heat shock protein 90 in pancreatic cancer impairs insulin-like growth factor-I receptor signaling, disrupts an interleukin-6/signal-transducer and activator of transcription 3/hypoxia-inducible factor-1alpha autocrine loop, and reduces orthotopic tumor growth.

Lang SA, Moser C, Gaumann A, Klein D, Glockzin G, Popp FC, Dahlke MH, Piso P, Schlitt HJ, Geissler EK, Stoeltzing O. Lang SA, et al. Clin Cancer Res. 2007 Nov 1;13(21):6459-68. doi: 10.1158/1078-0432.CCR-07-1104. Clin Cancer Res. 2007. PMID: 17975158

3

Non-benzoquinone geldanamycin analogs trigger various forms of death in human breast cancer cells.

Zhang Z, Li HM, Zhou C, Li Q, Ma L, Zhang Z, Sun Y, Wang L, Zhang X, Zhu B, Hong YS, Wu CZ, Liu H. Zhang Z, et al. J Exp Clin Cancer Res. 2016 Sep 22;35(1):149. doi: 10.1186/s13046-016-0428-6. J Exp Clin Cancer Res. 2016. PMID: 27658586 Free PMC article.

4

Inhibition of heat shock protein 90 impairs epidermal growth factor-mediated signaling in gastric cancer cells and reduces tumor growth and vascularization in vivo.

Lang SA, Klein D, Moser C, Gaumann A, Glockzin G, Dahlke MH, Dietmaier W, Bolder U, Schlitt HJ, Geissler EK, Stoeltzing O. Lang SA, et al. Mol Cancer Ther. 2007 Mar;6(3):1123-32. doi: 10.1158/1535-7163.MCT-06-0628. Mol Cancer Ther. 2007. PMID: 17363505

5

The combination of Hsp90 inhibitor 17AAG and heavy-ion irradiation provides effective tumor control in human lung cancer cells.

Hirakawa H, Fujisawa H, Masaoka A, Noguchi M, Hirayama R, Takahashi M, Fujimori A, Okayasu R. Hirakawa H, et al. Cancer Med. 2015 Mar;4(3):426-36. doi: 10.1002/cam4.377. Epub 2015 Jan 13. Cancer Med. 2015. PMID: 25582113 Free PMC article.

6

Preclinical antitumor activity of the novel heat shock protein 90 inhibitor CH5164840 against human epidermal growth factor receptor 2 (HER2)-overexpressing cancers.

Ono N, Yamazaki T, Nakanishi Y, Fujii T, Sakata K, Tachibana Y, Suda A, Hada K, Miura T, Sato S, Saitoh R, Nakano K, Tsukuda T, Mio T, Ishii N, Kondoh O, Aoki Y. Ono N, et al. Cancer Sci. 2012 Feb;103(2):342-9. doi: 10.1111/j.1349-7006.2011.02144.x. Epub 2011 Dec 13. Cancer Sci. 2012. PMID: 22050138 Free article.

7

[Study on signal transduction pathway in differentiation and apoptosis of leukemia cells induced by heat shock protein inhibitor].

Yu WJ, Rao Q, Wang M, Tian Z, Xu ZF, Wang JX. Yu WJ, et al. Zhonghua Xue Ye Xue Za Zhi. 2007 Oct;28(10):677-80. Zhonghua Xue Ye Xue Za Zhi. 2007. PMID: 18399173 Chinese.

8

Effect of mesoporous silica nanoparticles co‑loading with 17‑AAG and Torin2 on anaplastic thyroid carcinoma by targeting VEGFR2.

Wang C, Zhang R, Tan J, Meng Z, Zhang Y, Li N, Wang H, Chang J, Wang R. Wang C, et al. Oncol Rep. 2020 May;43(5):1491-1502. doi: 10.3892/or.2020.7537. Epub 2020 Mar 9. Oncol Rep. 2020. PMID: 32323855 Free PMC article.

9

Comparison of inhibitory effects of 17-AAG nanoparticles and free 17-AAG on HSP90 gene expression in breast cancer.

Ghalhar MG, Akbarzadeh A, Rahmati M, Mellatyar H, Dariushnejad H, Zarghami N, Barkhordari A. Ghalhar MG, et al. Asian Pac J Cancer Prev. 2014;15(17):7113-8. doi: 10.7314/apjcp.2014.15.17.7113. Asian Pac J Cancer Prev. 2014. PMID: 25227799 Free article.

10

Small molecule inhibitor screening identifified HSP90 inhibitor 17-AAG as potential therapeutic agent for gallbladder cancer.

Weber H, Valbuena JR, Barbhuiya MA, Stein S, Kunkel H, García P, Bizama C, Riquelme I, Espinoza JA, Kurtz SE, Tyner JW, Calderon JF, Corvalán AH, Grez M, Pandey A, Leal-Rojas P, Roa JC. Weber H, et al. Oncotarget. 2017 Apr 18;8(16):26169-26184. doi: 10.18632/oncotarget.15410. Oncotarget. 2017. PMID: 28412732 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

326 results

Results by year